Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar 16;7(2):140-155.
eCollection 2021 Apr 22.

Current role of nanoparticles in the treatment of lung cancer

Eliseo Carrasco-Esteban  1 , José Antonio Domínguez-Rullán  2 , Patricia Barrionuevo-Castillo  3 , Lira Pelari-Mici  2 , Olwen Leaman  4 , Sara Sastre-Gallego  5 , Fernando López-Campos  2
Affiliations
Review

Current role of nanoparticles in the treatment of lung cancer

Eliseo Carrasco-Esteban et al. J Clin Transl Res. .

Abstract

Background: Worldwide, lung cancer is one of the leading causes of cancer death. Nevertheless, new therapeutic agents have been developed to treat lung cancer that could change this mortality-rate. Interestingly, incredible advances have occurred in recent years in the development and application of nanotechnology in the detection, diagnosis, and treatment of lung cancer.

Aim: Nanoparticles (NPs) have the ability to incorporate multiple drugs and targeting agents and therefore lead to an improved bioavailability, sustained delivery, solubility, and intestinal absorption.

Relevance for patients: This review briefly summarizes the latest innovations in therapeutic nanomedicine in lung cancer with examples on magnetic, lipid, and polymer NP. Emphasis will be placed on future studies and ongoing clinical trials in this field.

Keywords: drug delivery; lipid nanoparticles; lung cancer; magnetic nanoparticles; polymer nanoparticles.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest.

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global Cancer Statistics 2018:GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2018;68:394–424. - PubMed
    1. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2018. CA Cancer J Clin. 2018;68:7–30. - PubMed
    1. Rivera MP, Mehta AC, Wahidi MM. Establishing the Diagnosis of Lung Cancer:Diagnosis and Management of Lung Cancer:American College of Chest Physicians Evidence-based Clinical Practice Guidelines. Chest J. 2013;143:e142S–65. - PubMed
    1. Hochhegger B, Alves GR, Irion KL, Fritscher CC, Fritscher LG, Concatto NH, et al. PET/CT Imaging in Lung Cancer:Indications and Findings. J Bras Pneumol. 2015;41:264–74. - PMC - PubMed
    1. Kozower BD, Larner JM, Detterbeck FC, Jones DR. Special Treatment Issues in Non-Small Cell Lung Cancer:Diagnosis and Management of Lung Cancer:American College of Chest Physicians Evidence-based Clinical Practice Guidelines. Chest. 2013;143:e369S–99. - PubMed

LinkOut - more resources